Global Age Related Macular Degeneration Drug Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Age Related Macular Degeneration Drug market size is predicted to grow from US$ 8918 million in 2025 to US$ 12740 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
LP Information, Inc. (LPI) ' newest research report, the “Age Related Macular Degeneration Drug Industry Forecast” looks at past sales and reviews total world Age Related Macular Degeneration Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Age Related Macular Degeneration Drug sales for 2025 through 2031. With Age Related Macular Degeneration Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Age Related Macular Degeneration Drug industry.
This Insight Report provides a comprehensive analysis of the global Age Related Macular Degeneration Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Age Related Macular Degeneration Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Age Related Macular Degeneration Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Age Related Macular Degeneration Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Age Related Macular Degeneration Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Age Related Macular Degeneration Drug market?
What factors are driving Age Related Macular Degeneration Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Age Related Macular Degeneration Drug market opportunities vary by end market size?
How does Age Related Macular Degeneration Drug break out by Type, by Application?
The global Age Related Macular Degeneration Drug market size is predicted to grow from US$ 8918 million in 2025 to US$ 12740 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.
The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.
LP Information, Inc. (LPI) ' newest research report, the “Age Related Macular Degeneration Drug Industry Forecast” looks at past sales and reviews total world Age Related Macular Degeneration Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Age Related Macular Degeneration Drug sales for 2025 through 2031. With Age Related Macular Degeneration Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Age Related Macular Degeneration Drug industry.
This Insight Report provides a comprehensive analysis of the global Age Related Macular Degeneration Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Age Related Macular Degeneration Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Age Related Macular Degeneration Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Age Related Macular Degeneration Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Age Related Macular Degeneration Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lucentis
- Eylea
- Avastin
- Others
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Regeneron Pharmaceuticals
- Bayer HealthCare
- Novartis
- Roche
- Kanghong Pharma
What is the 10-year outlook for the global Age Related Macular Degeneration Drug market?
What factors are driving Age Related Macular Degeneration Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Age Related Macular Degeneration Drug market opportunities vary by end market size?
How does Age Related Macular Degeneration Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age Related Macular Degeneration Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Age Related Macular Degeneration Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Age Related Macular Degeneration Drug by Country/Region, 2020, 2024 & 2031
2.2 Age Related Macular Degeneration Drug Segment by Type
2.2.1 Lucentis
2.2.2 Eylea
2.2.3 Avastin
2.2.4 Others
2.3 Age Related Macular Degeneration Drug Sales by Type
2.3.1 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Age Related Macular Degeneration Drug Sale Price by Type (2020-2025)
2.4 Age Related Macular Degeneration Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Age Related Macular Degeneration Drug Sales by Application
2.5.1 Global Age Related Macular Degeneration Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Age Related Macular Degeneration Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Age Related Macular Degeneration Drug Breakdown Data by Company
3.1.1 Global Age Related Macular Degeneration Drug Annual Sales by Company (2020-2025)
3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
3.2 Global Age Related Macular Degeneration Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
3.3 Global Age Related Macular Degeneration Drug Sale Price by Company
3.4 Key Manufacturers Age Related Macular Degeneration Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Age Related Macular Degeneration Drug Product Location Distribution
3.4.2 Players Age Related Macular Degeneration Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AGE RELATED MACULAR DEGENERATION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Age Related Macular Degeneration Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Age Related Macular Degeneration Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Age Related Macular Degeneration Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Age Related Macular Degeneration Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Age Related Macular Degeneration Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Age Related Macular Degeneration Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Age Related Macular Degeneration Drug Sales Growth
4.4 APAC Age Related Macular Degeneration Drug Sales Growth
4.5 Europe Age Related Macular Degeneration Drug Sales Growth
4.6 Middle East & Africa Age Related Macular Degeneration Drug Sales Growth
5 AMERICAS
5.1 Americas Age Related Macular Degeneration Drug Sales by Country
5.1.1 Americas Age Related Macular Degeneration Drug Sales by Country (2020-2025)
5.1.2 Americas Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
5.2 Americas Age Related Macular Degeneration Drug Sales by Type (2020-2025)
5.3 Americas Age Related Macular Degeneration Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age Related Macular Degeneration Drug Sales by Region
6.1.1 APAC Age Related Macular Degeneration Drug Sales by Region (2020-2025)
6.1.2 APAC Age Related Macular Degeneration Drug Revenue by Region (2020-2025)
6.2 APAC Age Related Macular Degeneration Drug Sales by Type (2020-2025)
6.3 APAC Age Related Macular Degeneration Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Age Related Macular Degeneration Drug by Country
7.1.1 Europe Age Related Macular Degeneration Drug Sales by Country (2020-2025)
7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
7.2 Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025)
7.3 Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age Related Macular Degeneration Drug by Country
8.1.1 Middle East & Africa Age Related Macular Degeneration Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
10.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
10.4 Industry Chain Structure of Age Related Macular Degeneration Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Age Related Macular Degeneration Drug Distributors
11.3 Age Related Macular Degeneration Drug Customer
12 WORLD FORECAST REVIEW FOR AGE RELATED MACULAR DEGENERATION DRUG BY GEOGRAPHIC REGION
12.1 Global Age Related Macular Degeneration Drug Market Size Forecast by Region
12.1.1 Global Age Related Macular Degeneration Drug Forecast by Region (2026-2031)
12.1.2 Global Age Related Macular Degeneration Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Age Related Macular Degeneration Drug Forecast by Type (2026-2031)
12.7 Global Age Related Macular Degeneration Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Bayer HealthCare
13.2.1 Bayer HealthCare Company Information
13.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer HealthCare Main Business Overview
13.2.5 Bayer HealthCare Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Kanghong Pharma
13.5.1 Kanghong Pharma Company Information
13.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kanghong Pharma Main Business Overview
13.5.5 Kanghong Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Age Related Macular Degeneration Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Age Related Macular Degeneration Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Age Related Macular Degeneration Drug by Country/Region, 2020, 2024 & 2031
2.2 Age Related Macular Degeneration Drug Segment by Type
2.2.1 Lucentis
2.2.2 Eylea
2.2.3 Avastin
2.2.4 Others
2.3 Age Related Macular Degeneration Drug Sales by Type
2.3.1 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Age Related Macular Degeneration Drug Sale Price by Type (2020-2025)
2.4 Age Related Macular Degeneration Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Age Related Macular Degeneration Drug Sales by Application
2.5.1 Global Age Related Macular Degeneration Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Age Related Macular Degeneration Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Age Related Macular Degeneration Drug Breakdown Data by Company
3.1.1 Global Age Related Macular Degeneration Drug Annual Sales by Company (2020-2025)
3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
3.2 Global Age Related Macular Degeneration Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Age Related Macular Degeneration Drug Revenue by Company (2020-2025)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
3.3 Global Age Related Macular Degeneration Drug Sale Price by Company
3.4 Key Manufacturers Age Related Macular Degeneration Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Age Related Macular Degeneration Drug Product Location Distribution
3.4.2 Players Age Related Macular Degeneration Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AGE RELATED MACULAR DEGENERATION DRUG BY GEOGRAPHIC REGION
4.1 World Historic Age Related Macular Degeneration Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Age Related Macular Degeneration Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Age Related Macular Degeneration Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Age Related Macular Degeneration Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Age Related Macular Degeneration Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Age Related Macular Degeneration Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Age Related Macular Degeneration Drug Sales Growth
4.4 APAC Age Related Macular Degeneration Drug Sales Growth
4.5 Europe Age Related Macular Degeneration Drug Sales Growth
4.6 Middle East & Africa Age Related Macular Degeneration Drug Sales Growth
5 AMERICAS
5.1 Americas Age Related Macular Degeneration Drug Sales by Country
5.1.1 Americas Age Related Macular Degeneration Drug Sales by Country (2020-2025)
5.1.2 Americas Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
5.2 Americas Age Related Macular Degeneration Drug Sales by Type (2020-2025)
5.3 Americas Age Related Macular Degeneration Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Age Related Macular Degeneration Drug Sales by Region
6.1.1 APAC Age Related Macular Degeneration Drug Sales by Region (2020-2025)
6.1.2 APAC Age Related Macular Degeneration Drug Revenue by Region (2020-2025)
6.2 APAC Age Related Macular Degeneration Drug Sales by Type (2020-2025)
6.3 APAC Age Related Macular Degeneration Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Age Related Macular Degeneration Drug by Country
7.1.1 Europe Age Related Macular Degeneration Drug Sales by Country (2020-2025)
7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
7.2 Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025)
7.3 Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Age Related Macular Degeneration Drug by Country
8.1.1 Middle East & Africa Age Related Macular Degeneration Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
10.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
10.4 Industry Chain Structure of Age Related Macular Degeneration Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Age Related Macular Degeneration Drug Distributors
11.3 Age Related Macular Degeneration Drug Customer
12 WORLD FORECAST REVIEW FOR AGE RELATED MACULAR DEGENERATION DRUG BY GEOGRAPHIC REGION
12.1 Global Age Related Macular Degeneration Drug Market Size Forecast by Region
12.1.1 Global Age Related Macular Degeneration Drug Forecast by Region (2026-2031)
12.1.2 Global Age Related Macular Degeneration Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Age Related Macular Degeneration Drug Forecast by Type (2026-2031)
12.7 Global Age Related Macular Degeneration Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Information
13.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Regeneron Pharmaceuticals Main Business Overview
13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Bayer HealthCare
13.2.1 Bayer HealthCare Company Information
13.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer HealthCare Main Business Overview
13.2.5 Bayer HealthCare Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Kanghong Pharma
13.5.1 Kanghong Pharma Company Information
13.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolios and Specifications
13.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Kanghong Pharma Main Business Overview
13.5.5 Kanghong Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Age Related Macular Degeneration Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Age Related Macular Degeneration Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lucentis
Table 4. Major Players of Eylea
Table 5. Major Players of Avastin
Table 6. Major Players of Others
Table 7. Global Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 9. Global Age Related Macular Degeneration Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Age Related Macular Degeneration Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Age Related Macular Degeneration Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Age Related Macular Degeneration Drug Sale Market Share by Application (2020-2025)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Age Related Macular Degeneration Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 19. Global Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Age Related Macular Degeneration Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Age Related Macular Degeneration Drug Producing Area Distribution and Sales Area
Table 23. Players Age Related Macular Degeneration Drug Products Offered
Table 24. Age Related Macular Degeneration Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Age Related Macular Degeneration Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Age Related Macular Degeneration Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Age Related Macular Degeneration Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Age Related Macular Degeneration Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Age Related Macular Degeneration Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Age Related Macular Degeneration Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Age Related Macular Degeneration Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Age Related Macular Degeneration Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Age Related Macular Degeneration Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Age Related Macular Degeneration Drug
Table 54. Key Market Challenges & Risks of Age Related Macular Degeneration Drug
Table 55. Key Industry Trends of Age Related Macular Degeneration Drug
Table 56. Age Related Macular Degeneration Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Age Related Macular Degeneration Drug Distributors List
Table 59. Age Related Macular Degeneration Drug Customer List
Table 60. Global Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Age Related Macular Degeneration Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Age Related Macular Degeneration Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Age Related Macular Degeneration Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Age Related Macular Degeneration Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Age Related Macular Degeneration Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Age Related Macular Degeneration Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Regeneron Pharmaceuticals Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 76. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Regeneron Pharmaceuticals Main Business
Table 78. Regeneron Pharmaceuticals Latest Developments
Table 79. Bayer HealthCare Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 81. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bayer HealthCare Main Business
Table 83. Bayer HealthCare Latest Developments
Table 84. Novartis Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 86. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Roche Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 91. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Kanghong Pharma Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 96. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Kanghong Pharma Main Business
Table 98. Kanghong Pharma Latest Developments
Table 1. Age Related Macular Degeneration Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Age Related Macular Degeneration Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lucentis
Table 4. Major Players of Eylea
Table 5. Major Players of Avastin
Table 6. Major Players of Others
Table 7. Global Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 8. Global Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Table 9. Global Age Related Macular Degeneration Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Age Related Macular Degeneration Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Age Related Macular Degeneration Drug Sale by Application (2020-2025) & (K Units)
Table 13. Global Age Related Macular Degeneration Drug Sale Market Share by Application (2020-2025)
Table 14. Global Age Related Macular Degeneration Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Age Related Macular Degeneration Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Age Related Macular Degeneration Drug Sales by Company (2020-2025) & (K Units)
Table 18. Global Age Related Macular Degeneration Drug Sales Market Share by Company (2020-2025)
Table 19. Global Age Related Macular Degeneration Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Age Related Macular Degeneration Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Age Related Macular Degeneration Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Age Related Macular Degeneration Drug Producing Area Distribution and Sales Area
Table 23. Players Age Related Macular Degeneration Drug Products Offered
Table 24. Age Related Macular Degeneration Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Age Related Macular Degeneration Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Age Related Macular Degeneration Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Age Related Macular Degeneration Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Age Related Macular Degeneration Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Age Related Macular Degeneration Drug Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Age Related Macular Degeneration Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Age Related Macular Degeneration Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 36. Americas Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 39. Americas Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 40. APAC Age Related Macular Degeneration Drug Sales by Region (2020-2025) & (K Units)
Table 41. APAC Age Related Macular Degeneration Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Age Related Macular Degeneration Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 44. APAC Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 45. Europe Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 46. Europe Age Related Macular Degeneration Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 48. Europe Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Age Related Macular Degeneration Drug Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Age Related Macular Degeneration Drug Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Age Related Macular Degeneration Drug Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Age Related Macular Degeneration Drug
Table 54. Key Market Challenges & Risks of Age Related Macular Degeneration Drug
Table 55. Key Industry Trends of Age Related Macular Degeneration Drug
Table 56. Age Related Macular Degeneration Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Age Related Macular Degeneration Drug Distributors List
Table 59. Age Related Macular Degeneration Drug Customer List
Table 60. Global Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Age Related Macular Degeneration Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Age Related Macular Degeneration Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Age Related Macular Degeneration Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Age Related Macular Degeneration Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Age Related Macular Degeneration Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Age Related Macular Degeneration Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Age Related Macular Degeneration Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Age Related Macular Degeneration Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Regeneron Pharmaceuticals Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 76. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Regeneron Pharmaceuticals Main Business
Table 78. Regeneron Pharmaceuticals Latest Developments
Table 79. Bayer HealthCare Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Bayer HealthCare Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 81. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Bayer HealthCare Main Business
Table 83. Bayer HealthCare Latest Developments
Table 84. Novartis Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 86. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Roche Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 91. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Kanghong Pharma Basic Information, Age Related Macular Degeneration Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Kanghong Pharma Age Related Macular Degeneration Drug Product Portfolios and Specifications
Table 96. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Kanghong Pharma Main Business
Table 98. Kanghong Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Age Related Macular Degeneration Drug
Figure 2. Age Related Macular Degeneration Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Age Related Macular Degeneration Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Age Related Macular Degeneration Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Age Related Macular Degeneration Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2024)
Figure 10. Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lucentis
Figure 12. Product Picture of Eylea
Figure 13. Product Picture of Avastin
Figure 14. Product Picture of Others
Figure 15. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2025
Figure 16. Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2020-2025)
Figure 17. Age Related Macular Degeneration Drug Consumed in Hospitals
Figure 18. Global Age Related Macular Degeneration Drug Market: Hospitals (2020-2025) & (K Units)
Figure 19. Age Related Macular Degeneration Drug Consumed in Clinics
Figure 20. Global Age Related Macular Degeneration Drug Market: Clinics (2020-2025) & (K Units)
Figure 21. Age Related Macular Degeneration Drug Consumed in Others
Figure 22. Global Age Related Macular Degeneration Drug Market: Others (2020-2025) & (K Units)
Figure 23. Global Age Related Macular Degeneration Drug Sale Market Share by Application (2024)
Figure 24. Global Age Related Macular Degeneration Drug Revenue Market Share by Application in 2025
Figure 25. Age Related Macular Degeneration Drug Sales by Company in 2025 (K Units)
Figure 26. Global Age Related Macular Degeneration Drug Sales Market Share by Company in 2025
Figure 27. Age Related Macular Degeneration Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Age Related Macular Degeneration Drug Revenue Market Share by Company in 2025
Figure 29. Global Age Related Macular Degeneration Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Age Related Macular Degeneration Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 32. Americas Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 34. APAC Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 36. Europe Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Age Related Macular Degeneration Drug Sales Market Share by Country in 2025
Figure 40. Americas Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Age Related Macular Degeneration Drug Sales Market Share by Region in 2025
Figure 48. APAC Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 51. China Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Age Related Macular Degeneration Drug Sales Market Share by Country in 2025
Figure 59. Europe Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug in 2025
Figure 76. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 77. Industry Chain Structure of Age Related Macular Degeneration Drug
Figure 78. Channels of Distribution
Figure 79. Global Age Related Macular Degeneration Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Age Related Macular Degeneration Drug
Figure 2. Age Related Macular Degeneration Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Age Related Macular Degeneration Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Age Related Macular Degeneration Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Age Related Macular Degeneration Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2024)
Figure 10. Age Related Macular Degeneration Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Lucentis
Figure 12. Product Picture of Eylea
Figure 13. Product Picture of Avastin
Figure 14. Product Picture of Others
Figure 15. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2025
Figure 16. Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2020-2025)
Figure 17. Age Related Macular Degeneration Drug Consumed in Hospitals
Figure 18. Global Age Related Macular Degeneration Drug Market: Hospitals (2020-2025) & (K Units)
Figure 19. Age Related Macular Degeneration Drug Consumed in Clinics
Figure 20. Global Age Related Macular Degeneration Drug Market: Clinics (2020-2025) & (K Units)
Figure 21. Age Related Macular Degeneration Drug Consumed in Others
Figure 22. Global Age Related Macular Degeneration Drug Market: Others (2020-2025) & (K Units)
Figure 23. Global Age Related Macular Degeneration Drug Sale Market Share by Application (2024)
Figure 24. Global Age Related Macular Degeneration Drug Revenue Market Share by Application in 2025
Figure 25. Age Related Macular Degeneration Drug Sales by Company in 2025 (K Units)
Figure 26. Global Age Related Macular Degeneration Drug Sales Market Share by Company in 2025
Figure 27. Age Related Macular Degeneration Drug Revenue by Company in 2025 ($ millions)
Figure 28. Global Age Related Macular Degeneration Drug Revenue Market Share by Company in 2025
Figure 29. Global Age Related Macular Degeneration Drug Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Age Related Macular Degeneration Drug Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 32. Americas Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 33. APAC Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 34. APAC Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 35. Europe Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 36. Europe Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Age Related Macular Degeneration Drug Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Age Related Macular Degeneration Drug Revenue 2020-2025 ($ millions)
Figure 39. Americas Age Related Macular Degeneration Drug Sales Market Share by Country in 2025
Figure 40. Americas Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Figure 41. Americas Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 42. Americas Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 43. United States Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Age Related Macular Degeneration Drug Sales Market Share by Region in 2025
Figure 48. APAC Age Related Macular Degeneration Drug Revenue Market Share by Region (2020-2025)
Figure 49. APAC Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 50. APAC Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 51. China Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. India Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Age Related Macular Degeneration Drug Sales Market Share by Country in 2025
Figure 59. Europe Age Related Macular Degeneration Drug Revenue Market Share by Country (2020-2025)
Figure 60. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 61. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 62. Germany Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 63. France Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2020-2025)
Figure 70. Egypt Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Age Related Macular Degeneration Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug in 2025
Figure 76. Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure 77. Industry Chain Structure of Age Related Macular Degeneration Drug
Figure 78. Channels of Distribution
Figure 79. Global Age Related Macular Degeneration Drug Sales Market Forecast by Region (2026-2031)
Figure 80. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2026-2031)
